drug prices

Market Access

Looking to history to prepare for America’s uncertain future

In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration

Sales & Marketing

How buying Canadian insulin aids Americans without medical c...

The rising cost of medication in the United States has become a critical issue, significantly impacting the lives of millions across the nation.

Views & Analysis

close up of a prescription bottle with white tables falling out on top of a group of hundred dollar bills

How celebrity investor Mark Cuban is tackling out-of-control...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that

Market Access

Orphan drugs' financial success raises questions

R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.

News

Pharma bad boy Martin Shkreli is on the streets again

Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving AIDS drug by around 5,000%, has been released early from his seven-year prison term for de

News

Judge shuts down Servier's argument that NHS should have sto...

A London high court judge ruled this week that the damages paid to the NHS for an anticompetitive action by French pharma company Servier will not be reduced, despite an eyebrow-raising bid